Tandem Diabetes Care, Inc. announced that on August 17, 2023, Brian B. Hansen, Executive Vice President and Chief Commercial Officer of the company, notified the Company of his decision to resign from his role as Executive Vice President and Chief Commercial Officer, effective December 31, 2023 (Effective Date). In connection with Mr. Hansen?s resignation, Mr. Hansen and the Company entered into a Separation Agreement on August 18, 2023, under which Mr. Hansen will remain employed with the Company until June 28, 2024 (the Separation Date), but will be on administrative leave after the Effective Date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.23 USD | -4.19% | -0.97% | +73.19% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.19% | 3.31B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.25% | 42.5B | |
+15.97% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. Announces the Resignation of Brian B. Hansen as Executive Vice President and Chief Commercial Officer, Effective December 31, 2023